OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada
M. Sara Kuruvilla, Geoffrey Liu, Iqra Syed, et al.
Lung Cancer (2022) Vol. 173, pp. 58-66
Closed Access | Times Cited: 13
M. Sara Kuruvilla, Geoffrey Liu, Iqra Syed, et al.
Lung Cancer (2022) Vol. 173, pp. 58-66
Closed Access | Times Cited: 13
Showing 13 citing articles:
Multiple cancers escape from multiple MAPK pathway inhibitors and use DNA replication stress signaling to tolerate aberrant cell cycles
Timothy E. Hoffman, Varuna Nangia, C. Ryland Ill, et al.
Science Signaling (2023) Vol. 16, Iss. 796
Open Access | Times Cited: 13
Timothy E. Hoffman, Varuna Nangia, C. Ryland Ill, et al.
Science Signaling (2023) Vol. 16, Iss. 796
Open Access | Times Cited: 13
Prevalence of EGFR Mutations in Patients With Resected Stage I to III Nonsquamous Non–Small Cell Lung Cancer: Results of India Cohort
Ullas Batra, Kumar Prabhash, Vanita Noronha, et al.
JCO Global Oncology (2025), Iss. 11
Closed Access
Ullas Batra, Kumar Prabhash, Vanita Noronha, et al.
JCO Global Oncology (2025), Iss. 11
Closed Access
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives
Antonello Veccia, Mariachiara Dipasquale, M. Lorenzi, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 668-668
Open Access
Antonello Veccia, Mariachiara Dipasquale, M. Lorenzi, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 668-668
Open Access
Distribution of EGFR and KRAS Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review
Michele Piazzolla, Paola Parente, Flavia Centra, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 730-730
Open Access
Michele Piazzolla, Paola Parente, Flavia Centra, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 730-730
Open Access
Longitudinal Analysis of Recurrence and Risk Factors of Early-stage Resected Adenocarcinoma with Common EGFR Mutations: A Multicenter Retrospective Cohort Study in South Korea
June Hong Ahn, Sun Ha Choi, Sun Hyo Park, et al.
Clinical Lung Cancer (2025)
Closed Access
June Hong Ahn, Sun Ha Choi, Sun Hyo Park, et al.
Clinical Lung Cancer (2025)
Closed Access
Resected EGFR-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study)
J.B. Auliac, P. Thomas, O. Bylicki, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
J.B. Auliac, P. Thomas, O. Bylicki, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
Andre Verhoek, Parneet Cheema, Barbara Melosky, et al.
PharmacoEconomics - Open (2023) Vol. 7, Iss. 3, pp. 455-467
Open Access | Times Cited: 5
Andre Verhoek, Parneet Cheema, Barbara Melosky, et al.
PharmacoEconomics - Open (2023) Vol. 7, Iss. 3, pp. 455-467
Open Access | Times Cited: 5
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection
Hwa Kyung Park, Yoo Duk Choi, Ju‐Sik Yun, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5679-5679
Open Access | Times Cited: 4
Hwa Kyung Park, Yoo Duk Choi, Ju‐Sik Yun, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5679-5679
Open Access | Times Cited: 4
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection
Hwa Kyung Park, Yoo Duk Choi, Ju‐Sik Yun, et al.
(2023)
Open Access | Times Cited: 2
Hwa Kyung Park, Yoo Duk Choi, Ju‐Sik Yun, et al.
(2023)
Open Access | Times Cited: 2
Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment
Soo Jin Seung, Daniel Moldaver, Shazia Hassan, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 311-326
Open Access
Soo Jin Seung, Daniel Moldaver, Shazia Hassan, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 311-326
Open Access
Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers
Mariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 7, pp. 1505-1517
Open Access
Mariaenrica Tinè, Federica Pezzuto, Manuela Orlandi, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 7, pp. 1505-1517
Open Access
Cost-effectiveness of adjuvant icotinib versus chemotherapy for patients with stage II–IIIA EGFR-mutated non-small cell lung cancer in China
Lifeng Mu, Fulin Liu, Yulan Fang, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e081270-e081270
Open Access
Lifeng Mu, Fulin Liu, Yulan Fang, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e081270-e081270
Open Access
A single-center, cohort study of the mutational profile of Ukrainian patients with non-small cell lung cancer
О. І. Vynnychenko, Yuliia Moskalenko, Roman Moskalenko, et al.
Український радіологічний та онкологічний журнал (2024) Vol. 32, Iss. 4, pp. 504-517
Open Access
О. І. Vynnychenko, Yuliia Moskalenko, Roman Moskalenko, et al.
Український радіологічний та онкологічний журнал (2024) Vol. 32, Iss. 4, pp. 504-517
Open Access
